- Design
- Claims-based prescribing analysis with interaction database screening
- Population
- US adolescents and adults with sickle cell disease, commercially insured
- Primary outcome
- Interaction risk among the 100 most prescribed drugs
- Effect
- 43/100 drugs with interaction risk; CYP3A4 most common; oxycodone 40%, fentanyl 18.5%
A Clinical and Translational Science analysis used US commercial claims to list the 100 drugs most often prescribed to adolescents and adults with sickle cell disease, and checked each against a drug interaction database.
43 carried interaction risk. Inhibitors outnumbered inducers, and CYP3A4 accounted for the largest share. Two CYP3A4-metabolised opioids were among the most prescribed: oxycodone, in 40% of patients, and fentanyl, in 18.5%.
People with sickle cell disease take many drugs, often including opioids for pain alongside antimicrobials, antifungals and other agents that inhibit CYP3A4. A new inhibitor added to a stable opioid regimen can raise opioid levels and cause respiratory depression.
This is a desk analysis of potential interactions, not of harms that happened. It is a reminder to review the whole list whenever a CYP3A4-active drug is added.
- Review the full medication list in sickle cell disease whenever a new drug is started
- Check for CYP3A4 inhibitors when a patient is on oxycodone or fentanyl
- Monitor sedation and breathing if an inhibitor must be added to an opioid regimen
- Tell patients to report new drowsiness after any medicine change
Why it matters
Polypharmacy plus opioids makes interaction harm a predictable risk in this group.
Don't overread it
These are potential interactions from a database, not observed adverse events.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for clinical pharmacology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free